Science Explorer Back to mapMap
Discussion
Company · Hayward · United States

Aradigm (United States)

Research works
48
▼ 85% vs 2018-21
Citations
1.6k
34.1 per fractional work
Top-10% rate
30.6%
all institutions 10.0%
Open access
52%
world 40%
International
31%
world 18%

Not ranked overall: Aradigm (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Aradigm (United States) work in?

In all years, 53% of research at Aradigm (United States) is in Health Sciences, 25% in Life Sciences. Its largest fields are Medicine (50%), Pharmacology, Toxicology and Pharmaceutics (11%), Biochemistry, Genetics and Molecular Biology (8%). It does 2.0× the world's share of Health Sciences.

Health Sciences: 26 fractional works · 53.0% of its workMedicine: 24 fractional works · 50.1% of its workPulmonary and Respiratory Medicine: 16 fractional works · 32.7% of its workPhysiology: 2 fractional works · 4.5% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 2.5% of its workAnesthesiology and Pain Medicine: 1 fractional works · 2.2% of its workEpidemiology: 1 fractional works · 2.0% of its workInfectious Diseases: 1 fractional works · 1.2% of its workEmergency Medicine: 0 fractional works · 0.8% of its workFamily Practice: 0 fractional works · 0.7% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.7% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.5% of its workSurgery: 0 fractional works · 0.5% of its workPharmacology: 0 fractional works · 0.4% of its workNeurology: 0 fractional works · 0.4% of its workOncology: 0 fractional works · 0.4% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.3% of its workHealth Professions: 1 fractional works · 1.9% of its workEmergency Medical Services: 1 fractional works · 1.4% of its workSpeech and Hearing: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workDentistry: 0 fractional works · 0.7% of its workGeneral Dentistry: 0 fractional works · 0.7% of its workVeterinary: 0 fractional works · 0.4% of its workSmall Animals: 0 fractional works · 0.4% of its workLife Sciences: 12 fractional works · 25.2% of its workPharmacology, Toxicology and Pharmaceutics: 5 fractional works · 10.7% of its workPharmaceutical Science: 5 fractional works · 10.4% of its workPharmacology: 0 fractional works · 0.2% of its workBiochemistry, Genetics and Molecular Biology: 4 fractional works · 7.7% of its workMolecular Biology: 2 fractional works · 3.8% of its workMolecular Medicine: 1 fractional works · 1.4% of its workGenetics: 0 fractional works · 1.0% of its workBiophysics: 0 fractional works · 1.0% of its workBiotechnology: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNeuroscience: 3 fractional works · 5.4% of its workCognitive Neuroscience: 2 fractional works · 4.1% of its workCellular and Molecular Neuroscience: 0 fractional works · 1.0% of its workEndocrine and Autonomic Systems: 0 fractional works · 0.2% of its workImmunology and Microbiology: 1 fractional works · 1.1% of its workMicrobiology: 0 fractional works · 0.5% of its workParasitology: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 0 fractional works · 0.4% of its workFood Science: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPhysical Sciences: 9 fractional works · 18.0% of its workPhysics and Astronomy: 4 fractional works · 7.5% of its workAstronomy and Astrophysics: 2 fractional works · 3.2% of its workStatistical and Nonlinear Physics: 1 fractional works · 2.2% of its workAtomic and Molecular Physics, and Optics: 1 fractional works · 1.4% of its workInstrumentation: 0 fractional works · 0.8% of its workEngineering: 3 fractional works · 6.2% of its workCivil and Structural Engineering: 1 fractional works · 1.8% of its workBuilding and Construction: 1 fractional works · 1.2% of its workComputational Mechanics: 1 fractional works · 1.1% of its workBiomedical Engineering: 0 fractional works · 0.8% of its workOcean Engineering: 0 fractional works · 0.7% of its workElectrical and Electronic Engineering: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEnvironmental Science: 1 fractional works · 1.5% of its workGlobal and Planetary Change: 0 fractional works · 0.7% of its workNature and Landscape Conservation: 0 fractional works · 0.4% of its workEcology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.3% of its workMaterials Science: 1 fractional works · 1.3% of its workBiomaterials: 1 fractional works · 1.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workChemistry: 1 fractional works · 1.2% of its workSpectroscopy: 0 fractional works · 0.9% of its workAnalytical Chemistry: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.0% of its workEnergy: 0 fractional works · 0.2% of its workRenewable Energy, Sustainability and the Environment: 0 fractional works · 0.2% of its workSocial Sciences: 2 fractional works · 3.8% of its workSocial Sciences: 2 fractional works · 3.3% of its workSociology and Political Science: 1 fractional works · 1.7% of its workTransportation: 1 fractional works · 1.6% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.5% of its workEconomics and Econometrics: 0 fractional works · 0.5% of its workALL ITS WORKAradigm (UnitedStates)48fractional works, all years
Life Sciences25%Physical Sciences18%Health Sciences53%Social Sciences4%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 17 fields, with their numbers
    1. Medicine2450.1%
    2. Health Professions11.9%
    3. Dentistry00.7%
    4. Veterinary00.4%
    1. Pharmacology, Toxicology and Pharmaceutics510.7%
    2. Biochemistry, Genetics and Molecular Biology47.7%
    3. Neuroscience35.4%
    4. Immunology and Microbiology11.1%
    5. Agricultural and Biological Sciences00.4%
    1. Physics and Astronomy47.5%
    2. Engineering36.2%
    3. Environmental Science11.5%
    4. Materials Science11.3%
    5. Chemistry11.2%
    6. Energy00.2%
    1. Social Sciences23.3%
    2. Economics, Econometrics and Finance00.5%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.37× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 5.17× its world share, 0 worksImmunology and Micro…Neuroscience: 15.40× its world share, 2 worksNeuroscienceChemistry: 2.66× its world share, 0 worksChemistryEnvironmental Science: 0.84× its world share, 0 worksEnvironmental SciencePhysics and Astronomy: 16.86× its world share, 3 worksPhysics and AstronomyMedicine: 0.43× its world share, 1 worksMedicineSocial Sciences: 0.66× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Physics and Astronomy, 16.9×. Every wedge is a field page.

All 8 fields, with their numbers
  1. Physics and Astronomy16.86×3 works
  2. Neuroscience15.40×2 works
  3. Immunology and Microbiology5.17×0 works
  4. Chemistry2.66×0 works
  5. Biochemistry, Genetics and Molecular Biology1.37×1 works
  6. Environmental Science0.84×0 works
  7. Social Sciences0.66×1 works
  8. Medicine0.43×1 works

Who are the top researchers at Aradigm (United States)?

Ranked on the quality score, Juergen Froehlich, Matthew Dusan Paik and Richard J. Morishige lead among researchers whose main affiliation is Aradigm (United States).

  1. 1 Juergen Froehlich United States · #908,081 worldwide 1.6k citations · 37 works
  2. 2 Matthew Dusan Paik United States · #2,229,436 worldwide 10 citations · 18 works
  3. 3 Richard J. Morishige United States · #3,296,122 worldwide 397 citations · 17 works
  4. 4 Jerry K. Okikawa United States · #3,635,988 worldwide 459 citations · 15 works
  5. 5 Jeff Schuster United States · #3,770,234 worldwide 142 citations · 24 works
All ranked researchers at Aradigm (United States)

What are the most cited papers from Aradigm (United States)?

The most cited paper from Aradigm (United States) is "Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial" (David J. Serisier, Diana Bilton, Anthony De Soyza et al., 2013), with 250 citations. Next come "Production of solid lipid nanoparticle suspensions using supercritical fluid extraction of emulsions (SFEE) for pulmonary delivery using the AERx system☆" (225) and "Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials" (214).

Most cited papers
#PaperReleasedCitations
1 Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial David J. Serisier, Diana Bilton, Anthony De Soyza et al. · Thorax Open access 16 May 2013 250
2 Production of solid lipid nanoparticle suspensions using supercritical fluid extraction of emulsions (SFEE) for pulmonary delivery using the AERx system☆ Pradipta Chattopadhyay, Boris Yu Shekunov, DaBin Yim et al. · Advanced Drug Delivery Reviews 24 May 2007 225
3 Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials Charles Haworth, Diana Bilton, James Duncan Chalmers et al. · The Lancet Respiratory Medicine Open access 15 Jan 2019 214
4 Inhalation of hypertonic saline aerosol enhances mucociliary clearance in asthmatic and healthy subjects Evangelia Daviskas, Sandra D. Anderson, Igor Gonda et al. · European Respiratory Journal Open access Apr 1996 186
5 Development of Liposomal Ciprofloxacin to Treat Lung Infections David C. Cipolla, Jim Blanchard, Igor Gonda · Pharmaceutics Open access Mar 2016 176
All 60 most cited papers, with filters and sorting

Which keywords describe research at Aradigm (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Nanoparticles, Inhaler Devices, Pulmonary Drug Delivery, Cystic Fibrosis, Pulmonary Infections, Bronchiectasis, CFTR and Drug Delivery.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 31 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 31 words, with their numbers
  1. Nanoparticles12▲ 19×8 topics
  2. Inhaler Devices9▲ 606×1 topic
  3. Pulmonary Drug Delivery9▲ 606×1 topic
  4. Cystic Fibrosis4▲ 108×2 topics
  5. Pulmonary Infections4▲ 152×2 topics
  6. Bronchiectasis4▲ 297×1 topic
  7. CFTR4▲ 297×1 topic
  8. Epidemiology4▲ 1.88×13 topics
  9. Drug Delivery3▲ 12×2 topics
  10. Treatment3▲ 4.3×5 topics
  11. Chitosan2▲ 82×1 topic
  12. Mucosal2▲ 163×1 topic
  13. Climate Change2▲ 1.33×3 topics
  14. Pathogenesis2▲ 6.1×6 topics
  15. Microneedles2▲ 151×1 topic
  16. Pain Management2▲ 14×5 topics
  17. Solid Lipid Nanoparticles2▲ 151×1 topic
  18. Allergic Diseases2▲ 40×1 topic
  19. Antibiotic Resistance2▲ 7.5×5 topics
  20. Asthma2▲ 25×1 topic
  21. Bronchopulmonary Dysplasia2▲ 36×1 topic
  22. Preterm Infants2▲ 20×1 topic
  23. Spectroscopy1▲ 8.8×2 topics
  24. Biodiversity1▲ 3.2×3 topics
  25. Cyclodextrins1▲ 108×1 topic
  26. Solid Dispersions1▲ 108×1 topic
  27. Sustainability1▲ 1.36×3 topics
  28. Pain Assessment Tools1▲ 45×2 topics
  29. Public Health1▲ 1.61×3 topics
  30. Medication Adherence1▲ 37×2 topics
  31. Quantum Mechanics1▲ 24×2 topics

Which research topics does Aradigm (United States) publish most on?

By volume in 2022-now: Innovation, Sustainability, Human-Machine Systems, Visual perception and processing mechanisms, Optical and Acousto-Optic Technologies and Embodied and Extended Cognition.

  1. 1 Innovation, Sustainability, Human-Machine Systems Sociology and Political Science 1 works
  2. 2 Visual perception and processing mechanisms Cognitive Neuroscience 1 works
  3. 3 Optical and Acousto-Optic Technologies Atomic and Molecular Physics, and Optics 1 works
  4. 4 Embodied and Extended Cognition Cognitive Neuroscience 1 works
  5. 5 Scientific Research and Discoveries Statistical and Nonlinear Physics 1 works
  6. 6 Cognitive Science and Education Research Cognitive Neuroscience 1 works
  7. 7 Astronomy and Astrophysical Research Instrumentation 0 works
  8. 8 Cosmology and Gravitation Theories Astronomy and Astrophysics 0 works
  9. 9 Molecular spectroscopy and chirality Spectroscopy 0 works
  10. 10 Solar and Space Plasma Dynamics Astronomy and Astrophysics 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available52.3%not open47.7%

World: 40% of research is openly available.

with international co-authors31.1%domestic only68.9%

World: 18% is written across borders.

How has Aradigm (United States)'s research output changed?

Output in 2022-2025 was 85% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Aradigm (United States) as a percentage of every work published that year, 0.000031% in 2020.

still counting0.00020%0.00040%Aradigm (United States)0.000013% in 20251990200020102020

Fractional works of Aradigm (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Hayward

All research institutions in Hayward

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Aradigm (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.